Our top pick for
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Australian Pharmaceutical Industries is a medical distribution business based in Australia. Australian Pharmaceutical Industries shares (API) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Australian Pharmaceutical Industries has a trailing 12-month revenue of around $4 billion. If you're looking to buy shares, check out the steps below.
|52-week range||$1.0198 - $1.6964|
|50-day moving average||$1.5249|
|200-day moving average||$1.4944|
|Dividend yield||$0.035 (2.29%)|
|Earnings per share (TTM)||$0.003|
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
|3 months (2022-03-25)||1.53|
|6 months (2021-12-24)||-11.56%|
|1 year (2021-06-25)||36.00%|
|2 years (2020-06-26)||34.80%|
|3 years (2019-06-27)||17.69%|
|5 years (2017-06-27)||-17.96%|
Valuing Australian Pharmaceutical Industries stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Australian Pharmaceutical Industries's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Australian Pharmaceutical Industries's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 510x. In other words, Australian Pharmaceutical Industries shares trade at around 510x recent earnings.
That's relatively high compared to, say, the P/E ratio for the ASX over the 12 months to December 2019 (32.14). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Australian Pharmaceutical Industries's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.53. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Australian Pharmaceutical Industries's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Australian Pharmaceutical Industries's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $81 million (£0.0 million).
The EBITDA is a measure of a Australian Pharmaceutical Industries's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$4 billion|
|Operating margin TTM||1.59%|
|Gross profit TTM||$503 million|
|Return on assets TTM||2.59%|
|Return on equity TTM||0.26%|
|Market capitalisation||$753.8 million|
TTM: trailing 12 months
Dividend payout ratio: 1250% of net profits
Recently Australian Pharmaceutical Industries has paid out, on average, around 1250% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.29% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Australian Pharmaceutical Industries shareholders could enjoy a 2.29% return on their shares, in the form of dividend payments. In Australian Pharmaceutical Industries's case, that would currently equate to about A$0.035 per share.
Australian Pharmaceutical Industries's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
The latest dividend was paid out to all shareholders who bought their shares by 25 March 2022 (the "ex-dividend date").
Australian Pharmaceutical Industries's shares were split on 23 October 2009.
Over the last 12 months, Australian Pharmaceutical Industries's shares have ranged in value from as little as $1.0198 up to $1.6964. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (AU average) beta is 1, while Australian Pharmaceutical Industries's is 0.1833. This would suggest that Australian Pharmaceutical Industries's shares are less volatile than average (for this exchange).
Australian Pharmaceutical Industries Limited engages in the wholesale distribution and retail of pharmaceutical, medical, health, beauty, and lifestyle products to pharmacies primarily in Australia, New Zealand, and Asian markets. It offers health and beauty products through a network of Priceline and Priceline Pharmacy franchise stores, company-owned Priceline stores, and Clear Skincare network of clinics. The company also provides non-invasive aesthetic beauty services. Australian Pharmaceutical Industries Limited was incorporated in 1910 and is based in Camberwell, Australia. As of March 31, 2022, Australian Pharmaceutical Industries Limited operates as a subsidiary of WFM Investments Pty Ltd.
Steps to owning and managing Nexgen Energy shares.
Steps to owning and managing Keypath Education shares.
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
Steps to owning and managing EBR Systems shares.
Steps to owning and managing 5E Advanced Materials shares.
Steps to owning and managing Leo lithium shares.
Steps to owning and managing Besra Gold shares.
Steps to owning and managing The Lottery Corporation shares.
Steps to owning and managing Endeavour Group shares.
finder.com.au is one of Australia's leading comparison websites. We compare from a wide set of banks, insurers and product issuers. We value our editorial independence and follow editorial guidelines.
finder.com.au has access to track details from the product issuers listed on our sites. Although we provide information on the products offered by a wide range of issuers, we don't cover every available product or service.
Please note that the information published on our site should not be construed as personal advice and does not consider your personal needs and circumstances. While our site will provide you with factual information and general advice to help you make better decisions, it isn't a substitute for professional advice. You should consider whether the products or services featured on our site are appropriate for your needs. If you're unsure about anything, seek professional advice before you apply for any product or commit to any plan.
Products marked as 'Promoted' or 'Advertisement' are prominently displayed either as a result of a commercial advertising arrangement or to highlight a particular product, provider or feature. Finder may receive remuneration from the Provider if you click on the related link, purchase or enquire about the product. Finder's decision to show a 'promoted' product is neither a recommendation that the product is appropriate for you nor an indication that the product is the best in its category. We encourage you to use the tools and information we provide to compare your options.
Where our site links to particular products or displays 'Go to site' buttons, we may receive a commission, referral fee or payment when you click on those buttons or apply for a product. You can learn more about how we make money here.
When products are grouped in a table or list, the order in which they are initially sorted may be influenced by a range of factors including price, fees and discounts; commercial partnerships; product features; and brand popularity. We provide tools so you can sort and filter these lists to highlight features that matter to you.
We try to take an open and transparent approach and provide a broad-based comparison service. However, you should be aware that while we are an independently owned service, our comparison service does not include all providers or all products available in the market.
Some product issuers may provide products or offer services through multiple brands, associated companies or different labelling arrangements. This can make it difficult for consumers to compare alternatives or identify the companies behind the products. However, we aim to provide information to enable consumers to understand these issues.
Providing or obtaining an estimated insurance quote through us does not guarantee you can get the insurance. Acceptance by insurance companies is based on things like occupation, health and lifestyle. By providing you with the ability to apply for a credit card or loan, we are not guaranteeing that your application will be approved. Your application for credit products is subject to the Provider's terms and conditions as well as their application and lending criteria.